Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 7.03 is 57% above its 5-year average of 4.49, near the high end of its 5-year range (1.54–7.50).
As of the fiscal period ended Tuesday, June 30, 2026. 44.14% above its 12-month average of 4.88.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.03.
QUICK RATIO (ACID-TEST)
7.03
QUICK RATIO (ACID-TEST) AVG TTM
4.88
QUICK RATIO (ACID-TEST) AVG 3Y
3.95
QUICK RATIO (ACID-TEST) AVG 5Y
4.49
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+44.14%
CURRENT VS 3Y AVG
+78.11%
CURRENT VS 5Y AVG
+56.50%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.28
median of 797 covered companies
CURRENT VS SECTOR MEDIAN
+114.25%
vs the sector median at left
Cognition Therapeutics, Inc.
Market Cap
$84.54M
Quick Ratio (Acid-Test)
7.03
TTM Avg
4.88
3Y Avg
3.95
5Y Avg
4.49
Market Cap
$84.25M
Quick Ratio (Acid-Test)
5.74
TTM Avg
2.67
3Y Avg
4.44
5Y Avg
7.03
Market Cap
$84.03M
Quick Ratio (Acid-Test)
7.85
TTM Avg
4.70
3Y Avg
2.98
5Y Avg
5.25
Market Cap
$83.68M
Quick Ratio (Acid-Test)
8.75
TTM Avg
11.02
3Y Avg
14.04
5Y Avg
18.21
Market Cap
$82.85M
Quick Ratio (Acid-Test)
3.30
TTM Avg
5.38
3Y Avg
8.10
5Y Avg
12.75
Market Cap
$86.90M
Quick Ratio (Acid-Test)
1.01
TTM Avg
1.14
3Y Avg
1.20
5Y Avg
1.25
Market Cap
$87.20M
Quick Ratio (Acid-Test)
1.98
TTM Avg
0.61
3Y Avg
1.40
5Y Avg
2.59
Market Cap
$81.86M
Quick Ratio (Acid-Test)
7.99
TTM Avg
9.12
3Y Avg
12.06
5Y Avg
14.25
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cognition Therapeutics, Inc. (CGTX) | $84.54M | 7.03 | 4.88 | 3.95 | 4.49 |
| Humacyte, Inc. (HUMA)vs › | $84.25M | 5.74 | 2.67 | 4.44 | 7.03 |
| ProMIS Neurosciences, Inc. (PMN)vs › | $84.03M | 7.85 | 4.70 | 2.98 | 5.25 |
| MediciNova, Inc. (MNOV)vs › | $83.68M | 8.75 | 11.02 | 14.04 | 18.21 |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.85M | 3.30 | 5.38 | 8.10 | 12.75 |
| LENSAR Inc (LNSR)vs › | $82.29M | 1.13 | 1.33 | 1.81 | 2.82 |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 1.01 | 1.14 | 1.20 | 1.25 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $87.20M | 1.98 | 0.61 | 1.40 | 2.59 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $81.86M | 7.99 | 9.12 | 12.06 | 14.25 |
| Nutriband Inc. (NTRB)vs › | $80.78M | 4.02 | 5.44 | 3.75 | 3.66 |
Quick Ratio
7.03
Excludes inventory
Current Ratio
7.03
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 7.03 |
| 2026-03-31 | 5.92 |
| 2025-12-31 | 3.45 |
| 2025-09-30 | 6.44 |
| 2025-06-30 | 1.54 |
| 2025-03-31 | 2.09 |
| 2024-12-31 | 2.65 |
| 2024-09-30 | 2.11 |
| 2024-06-30 | 3.07 |
| 2024-03-31 | 4.00 |
| 2023-12-31 | 3.37 |
| 2023-09-30 | 4.38 |
| 2023-06-30 | 5.25 |
| 2023-03-31 | 5.73 |
| 2022-12-31 | 6.11 |
| 2022-09-30 | 4.20 |
| 2022-06-30 | 7.44 |
| 2022-03-31 | 7.38 |
| 2021-12-31 | 7.50 |
| 2021-09-30 | 2.27 |
| 2021-06-30 | 2.36 |
| 2021-03-31 | 3.62 |
| 2020-12-31 | 2.13 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
